A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis
Crossref DOI link: https://doi.org/10.1007/s00280-017-3495-2
Published Online: 2017-12-04
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanke, Nina
Teifel, Michael
Moj, Daniel
Wojtyniak, Jan-Georg
Britz, Hannah
Aicher, Babette
Sindermann, Herbert
Ammer, Nicola
Lehr, Thorsten
Funding for this research was provided by:
Aeterna Zentaris
License valid from 2017-12-04